Primary pure non-gestational choriocarcinoma of ovary: a rare case report
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20174086Keywords:
Choriocarcinoma, Non-gestational, PureAbstract
Germ cell malignancies represent 15% of ovarian cancers. Choriocarcinoma is a malignant tumour with trophoblastic differentiation. It may be gestational or non-gestational and may be a primary tumour or metastatic from other organs. Pure non-gestational choriocarcinoma is an extremely rare neoplasm, with reports of only a few cases. This study reports a rare case of non-gestational pure choriocarcinoma in a postmenarcheal young female and describes details of the tumour, including the clinicopathological findings. A young female presented with sudden onset anxiety, abdominal distention, severe abdominal pain, and severe pallor. Clinically, she was diagnosed as a case of ruptured ectopic pregnancy, and was taken up for emergency laparotomy. A right ovarian mass of 5X7 cm was seen, which was ruptured and was bleeding profusely. Right salpingo-oophorectomy was done, and it was diagnosed histopathologically as primary pure non-gestational choriocarcinoma of ovary. This case report describes the histopathological and immunohistochemical findings of this rare entity, as well as the various methods to differentiate between cases of non-gestational and gestational choriocarcinoma of the ovary. This is important as non-gestational choriocarcinoma has a poorer prognosis in comparison with gestational. Also, the treatment regimen for the two differs.
References
Corakçi A, Ozeren S, Ozkan S, Gürbüz Y, Ustün H, Yücesoy I. Pure nongestational choriocarcinoma of ovary. Arch Gynecol Obstet. 2005;271(2):176-7.
Russell P, Farnsworth A, editors. Surgical Pathology of the Ovaries. 2nd ed. Churchill Livingstone; Edinburgh: Non-gestational choriocarcinomas; 1997:263-4.
Scully RE, Young RH, Clement PB, editors. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Atlas of Tumor Pathology. 3rd series. Fascicle. Vol. 23. Armed Forces Institute of Pathology; Washington DC: Choriocarcinoma;1998:258-60.
Goswami D, Sharma K, Zutshi V, Tempe A, Nigam S. Nongestational pure ovarian choriocarcinoma with contralateral teratoma. Gynecol Oncol. 2001;80:262-6.
Inaba H, Kawasaki H, Hamazaki M, Okugawa T, Uchida K, Honzumi M, et al. A case of metastatic ovarian non-gestational choriocarcinoma: successful treatment with conservative type surgery and myeloablative chemotherapy. Pediatr Int. 2000;42:383-5.
Scully RE. Hartmann WH, editor. Tumors of the ovary and mal-developed gonads. Atlas of tumor pathology. 1979:243-5.
Russell P, Farnsworth A. Surgical pathology of the ovaries. 2nd sub ed. Philadelphia: W.B. Saunders Company; 1997:785-7.
Gerbie MV, Brewer JI, Tamimi H. Primary choriocarcinoma of the ovary. Obstet Gynecol. 1975;46(6):720-3.
Lorigan PC, Colman RE, Hancock BW. The treatments of persistent trophoblastic disease using the Sheffield modification of chaing cross risk score. Proc Annu Meeting Am Soc Clin Oncol. 1994;13:257.
Rao KVLN, Konar S, Gangadharan J, Vikas V, Sampath S. A pure non-gestational ovarian choriocarcinoma with delayed solitary brain metastases: Case report and review of the literature. J Neurosci Rural Pract. 2015;6(4):578-81.
Tanaka K, Nabeshima Y, Takahashi H, Takeuchi S, Nabeshima Y, Ogata K. Lack of effective messenger RNA for beta 2-microglobulin in a gestational human choriocarcinoma cell line (GCH-1). Cancer Res. 1981;41(9 Pt 1):3639-41.
Kato M, Ohashi K, Saji F, Wakimoto A, Tanizawa O. Expression of HLA class I and beta 2-microglobulin on human choriocarcinoma cell lines: induction of HLA class I by interferon-gamma. Placenta. 1991;12(3):217-26.
Norman RJ, Jialal I, Joubert SM, Green-Thompson RW. Beta-2-microglobulin in trophoblastic disease. S Afr Med J. 1983;64(3):90-2.
Hayashi S, Abe Y, Tomita S, Nakanishi Y, Miwa S, Nakajima T, et al. Primary non-gestational pure choriocarcinoma arising in the ovary: A case report and literature review. Oncology Letters. 2015;9(5):2109-2111.
Koo HL, Choi J, Kim KR, Kim JH. Pure non-gestational choriocarcinoma of the ovary diagnosed by DNA polymorphism analysis. Pathol Int. 2006;56(10):613-6.
